Arkolith/Insider Trading/NBY/Form 4

Lazar David E.

10% OwnerNovaBay Pharmaceuticals, Inc. (NBY) · full profile →Form 4 · filed Jan 29, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 21, 2025Grant(A)6.4M——6.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 21, 2025Option exercise(M)40K——0

Transaction Codes

A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-26-000165) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML